, Tracking Stock Market Picks
Enter Symbol:
Nymox Pharmaceutical Corporation (NYMX) [hlAlert]

up 183.48 %

Nymox Pharmaceutical Corporation (NYMX) rated Sell by BioLogic Equity Research

Posted on: Tuesday,  Feb 15, 2011  8:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell Nymox Pharmaceutical Corporation (NASDAQ: NYMX) on 02/15/2011, when the stock price was $6.18.
Since then, Nymox Pharmaceutical Corporation has lost 64.72% as of 01/04/2016's recent price of $2.18.
If you would have followed this BioLogic Equity Research's recommendation on NYMX, you would have gained 183.48% of your investment in 1784 days.

Nymox Pharmaceutical Corporation (Nymox) is a biopharmaceutical company. The Company has a pipeline of drug and diagnostic products in development for the treatment of conditions and diseases, such as enlarged prostate (benign prostatic hyperplasia (BPH)), Alzheimer?s disease (AD), E. coli O157:H7, contamination of food and drink products, and bacterial infections and for the diagnosis of AD and other indications. Its wholly owned subsidiaries include Nymox Corporation and Serex Inc., which conduct research and development, and some of the manufacturing for NicAlert and TobacAlert. Nymox also has rights for the use of statin drugs for the treatment and prevention of Alzheimer?s disease.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/15/2011 8:25 AM Sell
as of 12/30/2011
1 Week down  -2.49 %
1 Month   
3 Months down  -0.48 %
1 YTD down  -33.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy